Ionis Pharmaceuticals
(NASDAQ) IONS
Ionis Pharmaceuticals Financials at a Glance
Market Cap
$11.92B
Revenue (TTM)
$943.38M
Net Income (TTM)
$380.99M
EPS (TTM)
$-2.47
P/E Ratio
-29.25
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$72.16
Volume
69,039
Open
$73.70
Price
$72.16
Volume
69,039
Open
$73.70
Previous Close
$72.16
Daily Range
$71.84 - $73.70
52-Week Range
$23.95 - $86.74
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$72.16
Volume
69,039
Open
$73.70
Previous Close
$72.16
Daily Range
$71.84 - $73.70
52-Week Range
$23.95 - $86.74
IONS News
IONS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ionis Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
1,402
CEO
Brett P. Monia, PhD
Website
www.ionis.comHeadquarters
Carlsbad, CA 92010, US
IONS Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
-41%
Net Income Margin
-40%
Return on Equity
-71%
Return on Capital
-14%
Return on Assets
-11%
Earnings Yield
-3.42%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.92B
Shares Outstanding
165.19M
Volume
69.04K
Short Interest
0.00%
Avg. Volume
2.30M
Financials (TTM)
Gross Profit
$928.00M
Operating Income
$382.00M
EBITDA
$286.75M
Operating Cash Flow
$268.58M
Capital Expenditure
$51.44M
Free Cash Flow
$320.03M
Cash & ST Invst.
$2.68B
Total Debt
$2.61B
Ionis Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$203.00M
-10.4%
Gross Profit
$195.00M
-12.5%
Gross Margin
96.06%
N/A
Market Cap
$11.92B
N/A
Market Cap/Employee
$11.15M
N/A
Employees
1,069
N/A
Net Income
$229.00M
-119.5%
EBITDA
$4.61B
+5823.4%
Quarterly Fundamentals
Net Cash
$62.67M
-92.9%
Accounts Receivable
$66.00M
-28.4%
Inventory
$10.05M
-19.7%
Long Term Debt
$2.16B
+53.6%
Short Term Debt
$453.15M
+4783.6%
Return on Assets
-10.81%
N/A
Return on Invested Capital
-13.94%
N/A
Free Cash Flow
$159.00M
-12.3%
Operating Cash Flow
$137.71M
-18.6%